13.84
price up icon0.36%   0.05
after-market Dopo l'orario di chiusura: 13.84
loading
Precedente Chiudi:
$13.79
Aprire:
$13.84
Volume 24 ore:
999.94K
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.10B
Reddito:
$113.31M
Utile/perdita netta:
$-57.51M
Rapporto P/E:
-10.18
EPS:
-1.36
Flusso di cassa netto:
$-20.55M
1 W Prestazione:
-6.49%
1M Prestazione:
+64.57%
6M Prestazione:
+125.41%
1 anno Prestazione:
+145.39%
Intervallo 1D:
Value
$13.42
$13.90
Intervallo di 1 settimana:
Value
$13.14
$14.77
Portata 52W:
Value
$3.50
$15.92

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Nome
Wave Life Sciences Ltd
Name
Telefono
617-949-2900
Name
Indirizzo
7 STRAITS VIEW, SINGAPORE
Name
Dipendente
268
Name
Cinguettio
@WAVELifeSci
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
WVE's Discussions on Twitter

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-27 Ripresa JP Morgan Overweight
2024-09-19 Iniziato B. Riley Securities Buy
2024-09-09 Iniziato JP Morgan Overweight
2024-05-15 Iniziato Wells Fargo Overweight
2023-12-19 Aggiornamento Leerink Partners Market Perform → Outperform
2023-07-05 Iniziato Raymond James Outperform
2023-05-24 Downgrade Jefferies Buy → Hold
2020-12-15 Ripresa H.C. Wainwright Buy
2020-10-23 Iniziato RBC Capital Mkts Sector Perform
2019-12-31 Downgrade SVB Leerink Outperform → Mkt Perform
2019-11-01 Iniziato Guggenheim Buy
2019-07-15 Iniziato Cowen Market Perform
2019-04-17 Reiterato H.C. Wainwright Buy
2018-08-07 Iniziato Stifel Buy
2018-07-23 Iniziato H.C. Wainwright Buy
2018-03-19 Reiterato Mizuho Buy
2017-02-15 Iniziato H.C. Wainwright Buy
2016-11-10 Ripresa Leerink Partners Outperform
2015-12-07 Iniziato JMP Securities Mkt Outperform
2015-12-07 Iniziato Jefferies Buy
2015-12-07 Iniziato Leerink Partners Outperform
2015-12-07 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

pulisher
03:42 AM

Wave Life Sciences (WVE) to Release Earnings on Tuesday - MarketBeat

03:42 AM
pulisher
Nov 04, 2024

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

B. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00 - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Nov 03, 2024
pulisher
Nov 03, 2024

Emerald Advisers LLC Purchases 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Nov 03, 2024
pulisher
Oct 31, 2024

Wave Life Sciences' (WVE) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Those who invested in Wave Life Sciences (NASDAQ:WVE) three years ago are up 195% - Simply Wall St

Oct 31, 2024
pulisher
Oct 30, 2024

Wave Life Sciences Highlights Growing Pipeline at Research - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Analysts Set Wave Life Sciences Ltd. (NASDAQ:WVE) Target Price at $19.44 - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know - Yahoo Finance

Oct 28, 2024
pulisher
Oct 27, 2024

(WVE) Technical Data - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 25, 2024

Wave Life Sciences stock slides 31% after company prices $100 million secondary share offering - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Can Wave Life Sciences Make Waves With Forward-53 DMD Trial Data? - RTTNews

Oct 25, 2024
pulisher
Oct 25, 2024

Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini - Scrip

Oct 25, 2024
pulisher
Oct 25, 2024

WAVE Life Sciences (STU:1U5) Growth Rank : 2 (As of Oct. 25, 2024) - GuruFocus.com

Oct 25, 2024
pulisher
Oct 24, 2024

WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal trials - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Moody Aldrich Partners LLC - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

1 Brand-New Big Reason to Buy This Biotech Stock Right Now - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

VRTX: 3 Pharma Stocks to Watch as Gene Therapy Gains Momentum - StockNews.com

Oct 23, 2024
pulisher
Oct 23, 2024

What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Oct 23, 2024
pulisher
Oct 22, 2024

RBC Capital raises WAVE Life Sciences stock target By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Venture funds, a new chapter for MS & Wave’s data: a BioCentury podcast - BioCentury

Oct 21, 2024
pulisher
Oct 21, 2024

Wave Life Sciences (NASDAQ:WVE) PT Raised to $15.00 at Royal Bank of Canada - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

Wave Life Sciences Rockets 70% on Historic RNA Editing Success - MSN

Oct 20, 2024
pulisher
Oct 20, 2024

Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga

Oct 20, 2024
pulisher
Oct 20, 2024

SG Americas Securities LLC Has $300,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Oct 20, 2024
pulisher
Oct 19, 2024

WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Insider Sale: President and CEO Paul Bolno Sells 90,474 Shares o - GuruFocus.com

Oct 19, 2024
pulisher
Oct 18, 2024

Wave Life Sciences' Chris Francis sells $2.86 million in shares By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 90,474 Shares - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Wave Life Sciences' Chris Francis sells $2.86 million in shares - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Leerink Partnrs Analysts Raise Earnings Estimates for WVE - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Wave Life Sciences Rockets 70% On Historic RNA Editing Success - Barchart

Oct 18, 2024
pulisher
Oct 17, 2024

WVE (WAVE Life Sciences) Change In Inventory : $0.0 Mil (TTM As of Jun. 2024) - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

WVE (WAVE Life Sciences) Earnings per Share (Diluted) : $-0.57 (TTM As of Jun. 2024) - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

Wave Life Sciences (NASDAQ:WVE) Shares Gap DownHere's What Happened - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Wave Life Sciences Shares Surge After RNA Editing Discovery - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

JPMorgan Chase & Co. Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $17.00 - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Wave claims first clinical RNA editing title in rare genetic disease - BioPharma-Reporter.com

Oct 17, 2024
pulisher
Oct 17, 2024

Takeda terminates deal with Wave - The Pharma Letter

Oct 17, 2024
pulisher
Oct 17, 2024

Wave Life Sciences (NASDAQ:WVE) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

WAVE Life Sciences stock's Buy rating and price target reaffirmed by H.C. Wainwright - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

WVE Stock Soars 74% as Wave Life Sciences Achieves RNA Editing Breakthrough - MoneyCheck

Oct 17, 2024
pulisher
Oct 17, 2024

Wave surges on first RNA editing data in humans - pharmaphorum

Oct 17, 2024
pulisher
Oct 16, 2024

Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury

Oct 16, 2024
pulisher
Oct 16, 2024

WAVE Life Sciences (FRA:1U5) 50-Day SMA : €5.85 (As of Oct. 16, 2024) - GuruFocus.com

Oct 16, 2024

Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Wave Life Sciences Ltd Azioni (WVE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Francis Chris
See Remarks
Oct 16 '24
Sale
13.67
208,836
2,855,051
0
BOLNO PAUL
President and CEO
Oct 16 '24
Sale
15.00
90,474
1,357,110
268,585
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):